Sage Therapeutics, Inc.
SEC CIK 1597553 · SAGE · last insider filing 2025-07-31
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Cola Michael F | Director | filed 2014–2025 |
| Frates James M | Director | filed 2014–2025 |
| Greene Barry E | Director · President and CEO | filed 2020–2025 |
| Germano Geno J | Director | filed 2016–2025 |
| Golumbeski George | Director | filed 2019–2025 |
| Barrett Elizabeth A. | Director | filed 2025–2025 |
| Federer Jessica | Director | filed 2023–2025 |
| Jonas Jeffrey M | Director · See Remarks | filed 2014–2024 |
| Barrett Elizabeth | Director | filed 2019–2024 |
| Paul Steven M | Director | filed 2014–2024 |
| Starr Kevin P | Director | filed 2014–2023 |
| Nayak Asha | Director | filed 2017–2019 |
| Pien Howard H | Director | filed 2014–2016 |
| Nelsen Robert | Director | filed 2014–2015 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Benecchi Christopher | Chief Operating Officer | filed 2021–2025 |
| Shiferman Gregory L. | See Remarks | filed 2024–2025 |
| Quirk Michael C. | See Remarks | filed 2025–2025 |
| Gault Laura | Chief Medical Officer | filed 2022–2025 |
| Iguchi Kimi | See Remarks | filed 2014–2024 |
| Cook Anne Marie | Senior VP, General Counsel | filed 2015–2024 |
| Robichaud Albert | Chief Scientific Officer | filed 2014–2023 |
| Kanes Stephen | Chief Medical Officer | filed 2014–2021 |
| Cloonan Michael | Chief Business Officer | filed 2017–2021 |
| Anderson Thomas | See Remarks | filed 2014–2017 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.